Prioritizing Innovation – How major players in medtech stay ahead of the curve

In the medtech industry, if you don’t innovate, you can’t compete.

While innovation and breakthrough technologies may be the core currency at startups, larger medical device firms have more to balance alongside research and development, making strategies for maintaining innovation essential to staying ahead of the curve.

Last month at Device Talks West, Medtronic (NYSE:MDT) neurovascular R&D global VP Nitin Salunke and Avanos Medical (NYSE: AVNS) R&D senior manager Shane Duffy spoke on how internal competition, strong leadership personalities and long-term strategies can help guide innovation at large medtech firms.